1. A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. (6th March 2018) Authors: Tolcher, Anthony; Flaherty, Keith; Shapiro, Geoffrey I.; Berlin, Jordan; Witzig, Thomas; Habermann, Thomas; Bullock, Andrea; Rock, Edwin; Elekes, Agnes; Lin, Chester; Kostic, Dusan; Ohi, Naoto; Rasco, Drew; Papadopoulos, Kyriakos P.; Patnaik, Amita; Smith, Lon; Cote, Gregory M. Journal: Oncologist Issue: Volume 23:Number 6(2018) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. (January 2022) Authors: Plummer, Ruth; Dean, Emma; Arkenau, Hendrik-Tobias; Redfern, Charles; Spira, Alexander I.; Melear, Jason M.; Chung, Ki Y.; Ferrer-Playan, Jordi; Goddemeier, Thomas; Locatelli, Giuseppe; Dong, Jennifer; Fleuranceau-Morel, Patricia; Diaz-Padilla, Ivan; Shapiro, Geoffrey I. Journal: Lung cancer Issue: Volume 163(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cabozantinib in Patients with Advanced Merkel Cell Carcinoma. (14th February 2018) Authors: Rabinowits, Guilherme; Lezcano, Cecilia; Catalano, Paul J.; McHugh, Patricia; Becker, Hailey; Reilly, Megan M.; Huang, Julian; Tyagi, Ayushi; Thakuria, Manisha; Bresler, Scott C.; Sholl, Lynette M.; Shapiro, Geoffrey I.; Haddad, Robert; DeCaprio, James A. Journal: Oncologist Issue: Volume 23:Number 7(2018) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). (2021) Authors: Mahdi, Haider; Hafez, Navid; Doroshow, Deborah; Sohal, Davendra; Keedy, Vickie; Do, Khanh T.; LoRusso, Patricia; Jürgensmeier, Juliane; Avedissian, Manuel; Sklar, Jeffrey; Glover, Colin; Felicetti, Brunella; Dean, Emma; Mortimer, Peter; Shapiro, Geoffrey I.; Eder, Joseph Paul Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characterization of Neutropenia in Advanced Cancer Patients Following Palbociclib Treatment Using a Population Pharmacokinetic‐Pharmacodynamic Modeling and Simulation Approach. (18th April 2017) Authors: Sun, Wan; O'Dwyer, Peter J.; Finn, Richard S.; Ruiz‐Garcia, Ana; Shapiro, Geoffrey I.; Schwartz, Gary K.; DeMichele, Angela; Wang, Diane Journal: Journal of clinical pharmacology Issue: Volume 57:Number 9(2017) Page Start: 1159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Efficacy of Olaparib in IDH1/IDH2-Mutant Mesenchymal Sarcomas. (2021) Authors: Eder, Joseph P.; Doroshow, Deborah B.; Do, Khanh T.; Keedy, Vicki L.; Sklar, Jeffrey S.; Glazer, Peter; Bindra, Ranjit; Shapiro, Geoffrey I. Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical Efficacy of Olaparib inIDH1/IDH2‐Mutant Mesenchymal Sarcomas. (December 2021) Authors: Eder, Joseph P.; Doroshow, Deborah B.; Do, Khanh T.; Keedy, Vicki L.; Sklar, Jeffrey S.; Glazer, Peter; Bindra, Ranjit; Shapiro, Geoffrey I. Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First‐in‐human trial of the PI3Kβ‐selective inhibitor SAR260301 in patients with advanced solid tumors. Issue 2 (4th October 2017) Authors: Bédard, Philippe L.; Davies, Michael A.; Kopetz, Scott; Juric, Dejan; Shapiro, Geoffrey I.; Luke, Jason J.; Spreafico, Anna; Wu, Bin; Castell, Christelle; Gomez, Corinne; Cartot‐Cotton, Sylvaine; Mazuir, Florent; Dubar, Michel; Micallef, Sandrine; Demers, Brigitte; Flaherty, Keith T. Journal: Cancer Issue: Volume 124:Issue 2(2018) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study. Issue 17 (25th April 2017) Authors: Ben‐Ami, Eytan; Barysauskas, Constance M.; Solomon, Sarah; Tahlil, Kadija; Malley, Rita; Hohos, Melissa; Polson, Kathleen; Loucks, Margaret; Severgnini, Mariano; Patel, Tara; Cunningham, Amy; Rodig, Scott J.; Hodi, F. Stephen; Morgan, Jeffrey A.; Merriam, Priscilla; Wagner, Andrew J.; Shapiro, Ge... Journal: Cancer Issue: Volume 123:Issue 17(2017) Page Start: 3285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors. Issue 1 (25th May 2018) Authors: Shapiro, Geoffrey I.; Kristeleit, Rebecca S.; Burris, Howard A.; LoRusso, Patricia; Patel, Manish R.; Drew, Yvette; Giordano, Heidi; Maloney, Lara; Watkins, Simon; Goble, Sandra; Jaw‐Tsai, Sarah; Xiao, Jim J. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 1(2019) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗